Skip to main content

ZA47 Pill - white capsule/oblong, 18mm

Pill with imprint ZA47 is White, Capsule/Oblong and has been identified as Divalproex Sodium Extended-Release 250 mg. It is supplied by BluePoint Laboratories.

Divalproex sodium is used in the treatment of Bipolar Disorder; Mania; Migraine Prevention; Epilepsy; Seizures and belongs to the drug class fatty acid derivative anticonvulsants. When treating epilepsy and manic episodes associated with bipolar disorder: There is positive evidence of human fetal risk during pregnancy. When treating migraine: Not for use in pregnancy. Divalproex sodium 250 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for ZA47

Divalproex Sodium Extended-Release

250 mg
18.00 mm
Prescription only
Drug Class
Fatty acid derivative anticonvulsants
Pregnancy Category
D - Positive evidence of risk - When treating epilepsy and manic episodes associated with bipolar disorder, X - Not for use in pregnancy - When treating migraine
CSA Schedule
Not a controlled drug
Labeler / Supplier
BluePoint Laboratories
Inactive Ingredients
hydroxypropyl cellulose, hypromelloses, soya lecithin, magnesium stearate, polyethylene glycol, polyvinyl alcohol, silicon dioxide, magnesium silicate, titanium dioxide, xanthan gum

Note: Inactive ingredients may vary.

Labelers / Repackagers

NDC Code Labeler / Repackager
68084-0310 Amerisource Health Services

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.